Pfizer UK appoints new MD
This article was originally published in Scrip
Executive Summary
Erik Nordkamp has been appointed managing director and head of Global Innovative Pharmaceutical business at Pfizer UK, taking over from Jonathan Emms who has been appointed global marketing lead for Pfizer's Global Established Pharmaceutical business. Mr Nordkamp joined Pfizer in 2010 and for the past year has led the firm's Greece, Cyprus and Malta, and the Global Innovative Pharmaceutical business. Prior to this, he worked for Pfizer in the UK as head of strategy for Primary Care Europe and Canada. Erik also served as president of PhRMA Innovation, a trade association, where he led the transformation of the forum, positioning it as the main representative body for the innovative pharmaceutical industry in Greece.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.